Therefore, this study hypothesizes that hirudin may delay the progression of CKD through regulating the “gut-renal axis” disorder and inhibiting the activation of the NLRP3 pathway, and experimental verification will be conducted. This evidence concerns the gene NLRP3 and chronic kidney disease.